SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-001080
Filing Date
2022-02-10
Accepted
2022-02-10 16:11:21
Documents
14
Period of Report
2022-02-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K me-20220210.htm   iXBRL 8-K 59992
2 EX-99.1 me-ex99_1.htm EX-99.1 796952
  Complete submission text file 0000950170-22-001080.txt   1044060

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT me-20220210_lab.xml EX-101.LAB 22578
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT me-20220210_pre.xml EX-101.PRE 14451
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT me-20220210_def.xml EX-101.DEF 14293
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT me-20220210.xsd EX-101.SCH 3380
8 EXTRACTED XBRL INSTANCE DOCUMENT me-20220210_htm.xml XML 4708
Mailing Address 223 NORTH MATHILDA AVENUE SUNNYVALE CA 94086
Business Address 223 NORTH MATHILDA AVENUE SUNNYVALE CA 94086 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 22614018
SIC: 2834 Pharmaceutical Preparations